Neil Gow (microbiologist)

Last updated

Neil Gow
Professor Neil Gow FMedSci FRS (cropped).jpg
Gow in 2016
Born (1957-11-30) 30 November 1957 (age 66)
Education
Alma mater
Scientific career
Fields
Institutions
Thesis Growth, physiology and ultrastructure of the pathogenic fungus Candida albicans  (1982)
Doctoral advisor Graham W. Gooday
Website www.abdn.ac.uk/ims/profiles/n.gow

Neil Andrew Robert Gow (born 30 November 1957) [3] is a British microbiologist who is a professor of microbiology and deputy vice chancellor at the University of Exeter. [4] Previously he served at the University of Aberdeen for 38 years [1] [2] and retains an honorary chair there. [5]

Contents

Education

Gow was educated Madras College and Perth Academy. [1] He studied at the University of Edinburgh and the University of Aberdeen where he was awarded a PhD in 1982 for research on the pathogenic fungus Candida albicans supervised by Graham Gooday. [6] [7]

Research and career

Gow's research career has been in the field of fungal biology and medical mycology. He is known for his discoveries in fungal biology and genetics, morphogenesis and pathogenesis. His studies of how the cell walls of fungal pathogenic species is assembled, responds to antifungal antibiotics and is recognised by the human immune system directly impacts on the design and use of antifungal drugs, diagnostics and immunotherapies for fungal diseases. [8] [9] [10] [11]

After his PhD, Gow worked in Denver before returning to Aberdeen, where he has developed a team that has recently[ when? ] become a Medical Research Council (MRC) Centre for Medical Mycology and is one of the largest centres in this field worldwide. He has helped co-ordinate UK training and research in medical mycology and has acted as President of the British Mycological Society, the International Society for Human and Animal Mycology (ISHAM) and the Microbiology Society. [12]

Awards and honours

Gow has received several awards for his research, he was elected a Fellow of the Academy of Medical Sciences (FMedSci),[ when? ] the Royal Society of Edinburgh (FRSE) [13] [ when? ] and the American Academy of Microbiology. He was elected a Fellow of the Royal Society (FRS) in 2016 [12] and a Fellow of the Royal Society of Biology (FRSB). [1] [ when? ]

Related Research Articles

<span class="mw-page-title-main">Candidiasis</span> Fungal infection due to any type of Candida

Candidiasis is a fungal infection due to any species of the genus Candida. When it affects the mouth, in some countries it is commonly called thrush. Signs and symptoms include white patches on the tongue or other areas of the mouth and throat. Other symptoms may include soreness and problems swallowing. When it affects the vagina, it may be referred to as a yeast infection or thrush. Signs and symptoms include genital itching, burning, and sometimes a white "cottage cheese-like" discharge from the vagina. Yeast infections of the penis are less common and typically present with an itchy rash. Very rarely, yeast infections may become invasive, spreading to other parts of the body. This may result in fevers, among other symptoms.

<span class="mw-page-title-main">Hypha</span> Long, filamentous structure in fungi and Actinobacteria

A hypha is a long, branching, filamentous structure of a fungus, oomycete, or actinobacterium. In most fungi, hyphae are the main mode of vegetative growth, and are collectively called a mycelium.

<i>Candida dubliniensis</i> Species of fungus

Candida dubliniensis is a fungal opportunistic pathogen originally isolated from AIDS patients. It is also occasionally isolated from immunocompetent individuals. It is of the genus Candida, very closely related to Candida albicans but forming a distinct phylogenetic cluster in DNA fingerprinting. It is most commonly isolated from oral cavities, and is also occasionally found in other anatomical sites.

<i>Candida albicans</i> Species of fungus

Candida albicans is an opportunistic pathogenic yeast that is a common member of the human gut flora. It can also survive outside the human body. It is detected in the gastrointestinal tract and mouth in 40–60% of healthy adults. It is usually a commensal organism, but it can become pathogenic in immunocompromised individuals under a variety of conditions. It is one of the few species of the genus Candida that cause the human infection candidiasis, which results from an overgrowth of the fungus. Candidiasis is, for example, often observed in HIV-infected patients. C. albicans is the most common fungal species isolated from biofilms either formed on (permanent) implanted medical devices or on human tissue. C. albicans, C. tropicalis, C. parapsilosis, and C. glabrata are together responsible for 50–90% of all cases of candidiasis in humans. A mortality rate of 40% has been reported for patients with systemic candidiasis due to C. albicans. By one estimate, invasive candidiasis contracted in a hospital causes 2,800 to 11,200 deaths yearly in the US. Nevertheless, these numbers may not truly reflect the true extent of damage this organism causes, given new studies indicating that C. albicans can cross the blood–brain barrier in mice.

<i>Candida</i> (fungus) Genus of ascomycete fungi

Candida is a genus of yeasts. It is the most common cause of fungal infections worldwide and the largest genus of medically important yeasts.

<span class="mw-page-title-main">Oral candidiasis</span> Fungal infection

Oral candidiasis (Acute pseudomembranous candidiasis),which is also known as oral thrush, among other names, is candidiasis that occurs in the mouth. That is, oral candidiasis is a mycosis (yeast/fungal infection) of Candida species on the mucous membranes of the mouth.

Candida parapsilosis is a fungal species of yeast that has become a significant cause of sepsis and of wound and tissue infections in immunocompromised people. Unlike Candida albicans and Candida tropicalis, C. parapsilosis is not an obligate human pathogen, having been isolated from nonhuman sources such as domestic animals, insects and soil. C. parapsilosis is also a normal human commensal and it is one of the fungi most frequently isolated from human hands. There are several risk factors that can contribute to C. parapsilosis colonization. Immunocompromised individuals and surgical patients, particularly those undergoing surgery of the gastrointestinal tract, are at high risk for infection with C. parapsilosis. There is currently no consensus on the treatment of invasive candidiasis caused by C. parapsilosis, although the therapeutic approach typically includes the removal of foreign bodies such as implanted prostheses and the administration of systemic antifungal therapy. amphotericin B and fluconazole are often used in the treatment of C. parapsilosis infection.

<i>Nakaseomyces glabratus</i> Species of fungus

Nakaseomyces glabratus is a species of haploid yeast of the genus Nakaseomyces, previously known as Candida glabrata. Despite the fact that no sexual life cycle has been documented for this species, N. glabratus strains of both mating types are commonly found. N. glabrata is generally a commensal of human mucosal tissues, but in today's era of wider human immunodeficiency from various causes, N. glabratus is often the second or third most common cause of candidiasis as an opportunistic pathogen. Infections caused by N. glabratus can affect the urogenital tract or even cause systemic infections by entrance of the fungal cells in the bloodstream (Candidemia), especially prevalent in immunocompromised patients.

<span class="mw-page-title-main">Sertaconazole</span> Antifungal medication

Sertaconazole, sold under the brand name Ertaczo among others, is an antifungal medication of the Benzothiophene class. It is available as a cream to treat skin infections such as athlete's foot.

<span class="mw-page-title-main">Dimorphic fungus</span> Fungi that can exist as mold or yeast

A dimorphic fungus is a fungus that can exist in the form of both mold and yeast. As this is usually brought about by a change in temperature, this fungus type is also described as a thermally dimorphic fungus. An example is Talaromyces marneffei, a human pathogen that grows as a mold at room temperature, and as a yeast at human body temperature.

Pathogenic fungi are fungi that cause disease in humans or other organisms. Although fungi are eukaryotic, many pathogenic fungi are microorganisms. Approximately 300 fungi are known to be pathogenic to humans; their study is called "medical mycology". Fungal infections are estimated to kill more people than either tuberculosis or malaria—about two million people per year.

<span class="mw-page-title-main">Blastoconidium</span>

A blastoconidium is an asexual holoblastic conidia formed through the blowing out or budding process of a yeast cell, which is a type of asexual reproduction that results in a bud arising from a parent cell. The production of a blastoconidium can occur along a true hyphae, pseudohyphae, or a singular yeast cell. The word "conidia" comes from the Greek word konis and eidos, konis meaning dust and eidos meaning like. The term "bud" comes from the Greek word blastos, which means bud. Yeasts such as Candida albicans and Cryptococcus neoformans produce these budded cells known as blastoconidia.

Mycobiota are a group of all the fungi present in a particular geographic region or habitat type. An analogous term for Mycobiota is funga.

<span class="mw-page-title-main">Hwp1</span>

Hwp1 is a protein (glycoprotein) located on the surface of an opportunistic diploid fungus called Candida albicans.

Pneumocandin B<sub>0</sub> Chemical compound

Pneumocandin B0, also known as pneumocandin B0, pneumocandin B(0), and hydroxy echinocandin, is an organic chemical compound with the formula C50H80N8O17, produced by the fungus Glarea lozoyensis.

Graham William Gooday (1942–2001) was a British molecular biologist. He was Professor of Microbiology at Aberdeen University. He was presented with the inaugural Fleming Prize Lecture for the Microbiological Society in 1976. He served as Director of the Institute of Marine Biology.

Beatrice B. "Bebe" Magee is an American biochemist and geneticist with expertise in molecular mycology and fungal genetics. She earned her B. A. in chemistry from Brandeis University in 1962 and her M. A. in biochemistry from the University of California, Berkeley, in 1964. She has been co-author on over 40 publications in peer-reviewed journals and an invited speaker at scientific meetings including Woods Hole and Cold Spring Harbor courses as well as at professional mycology societies.

<span class="mw-page-title-main">Kaustuv Sanyal</span> Indian molecular biologist, mycologist and professor

Kaustuv Sanyal is an Indian molecular biologist, mycologist and a professor at the Molecular Biology and Genetics Unit of the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR). He is known for his molecular and genetic studies of pathogenic yeasts such as Candida and Cryptococcus). An alumnus of Bidhan Chandra Krishi Viswavidyalaya and Madurai Kamaraj University from where he earned a BSc in agriculture and MSc in biotechnology respectively, Sanyal did his doctoral studies at Bose Institute to secure a PhD in Yeast genetics. He moved to the University of California, Santa Barbara, USA to work in the laboratory of John Carbon on the discovery of centromeres in Candida albicans. He joined JNCASR in 2005. He is a member of the Faculty of 1000 in the disciplines of Microbial Evolution and Genomics and has delivered invited speeches which include the Gordon Research Conference, EMBO conferences on comparative genomics and kinetochores. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2012. He has also been awarded with the prestigious Tata Innovation Fellowship in 2017. The National Academy of Sciences, India elected him as a fellow in 2014. He is also an elected fellow of Indian Academy of Sciences (2017), and the Indian National Science Academy (2018). In 2019, he has been elected to Fellowship in the American Academy of Microbiology (AAM), the honorific leadership group within the American Society for Microbiology. He was awarded the J.C. Bose National Fellowship in 2020.

Carol Kumamoto is an American microbiologist who is Professor of Molecular Biology & Microbiology at Tufts University. She investigates the filamentous growth of Candida albicans, a fungal pathogen that causes several diseases. She is also interested in how C. albicans interacts with its host during colonisation and invasive diseases. She is a Fellow of the American Association for the Advancement of Science and the American Academy of Microbiology.

<span class="mw-page-title-main">Frank Odds</span> English mycologist (1945–2020)

Frank C. Odds was an English mycologist. He studied Candida albicans, establishing how modern researchers study fungal pathogens and the diseases they cause.

References

  1. 1 2 3 4 Anon (2017). "Gow, Prof. Neil Andrew Robert" . Who's Who (online Oxford University Press  ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.U286513.(Subscription or UK public library membership required.)
  2. 1 2 {{ Google Scholar ID }} template missing ID and not present in Wikidata.
  3. Neil A. R. Gow at Library of Congress
  4. "University of Exeter". Exeter.ac.uk. Retrieved 28 November 2018.
  5. "Professor Neil Gow: Chair in Microbiology, University of Aberdeen". Aberdeen: abdn.ac.uk. Archived from the original on 17 May 2016.
  6. Gow, Neil Andrew Robert (1982). Growth, physiology and ultrastructure of the pathogenic fungus Candida albicans. jisc.ac.uk (PhD thesis). University of Aberdeen. OCLC   646445444. EThOS   uk.bl.ethos.354942.
  7. Gow, Neil A. R.; Gooday, Graham W. (1982). "Growth kinetics and morphology of colonies of the filamentous form of Candida albicans". Journal of General Microbiology. 128 (9): 2187–2194. doi: 10.1099/00221287-128-9-2187 . PMID   6757383.
  8. Odds, Frank C.; Brown, Alistair J.P.; Gow, Neil A.R. (2003). "Antifungal agents: mechanisms of action". Trends in Microbiology. 11 (6): 272–279. doi:10.1016/S0966-842X(03)00117-3. PMID   12823944.
  9. Netea, Mihai G.; Brown, Gordon D.; Kullberg, Bart Jan; Gow, Neil A. R. (2008). "An integrated model of the recognition of Candida albicans by the innate immune system". Nature Reviews Microbiology. 6 (1): 67–78. doi:10.1038/nrmicro1815. PMID   18079743. S2CID   1477651.
  10. Cormack, B. P.; Bertram, G.; Egerton, M.; Gow, N. A. R.; Falkow, S.; Brown, A. J. P. (1997). "Yeast-enhanced green fluorescent protein (yEGFP): a reporter of gene expression in Candida albicans". Microbiology. 143 (2): 303–311. doi: 10.1099/00221287-143-2-303 . PMID   9043107.
  11. Butler, Geraldine; Rasmussen, Matthew D.; Lin, Michael F.; Santos, Manuel A. S.; Sakthikumar, Sharadha; Munro, Carol A.; Rheinbay, Esther; Grabherr, Manfred; Forche, Anja; Reedy, Jennifer L.; Agrafioti, Ino; Arnaud, Martha B.; Bates, Steven; Brown, Alistair J. P.; Brunke, Sascha; Costanzo, Maria C.; Fitzpatrick, David A.; de Groot, Piet W. J.; Harris, David; Hoyer, Lois L.; Hube, Bernhard; Klis, Frans M.; Kodira, Chinnappa; Lennard, Nicola; Logue, Mary E.; Martin, Ronny; Neiman, Aaron M.; Nikolaou, Elissavet; Quail, Michael A.; Quinn, Janet; Santos, Maria C.; Schmitzberger, Florian F.; Sherlock, Gavin; Shah, Prachi; Silverstein, Kevin A. T.; Skrzypek, Marek S.; Soll, David; Staggs, Rodney; Stansfield, Ian; Stumpf, Michael P. H.; Sudbery, Peter E.; Srikantha, Thyagarajan; Zeng, Qiandong; Berman, Judith; Berriman, Matthew; Heitman, Joseph; Gow, Neil A. R.; Lorenz, Michael C.; Birren, Bruce W.; Kellis, Manolis; Cuomo, Christina A. (2009). "Evolution of pathogenicity and sexual reproduction in eight Candida genomes". Nature. 459 (7247): 657–662. Bibcode:2009Natur.459..657B. doi:10.1038/nature08064. PMC   2834264 . PMID   19465905.
  12. 1 2 Anon (2016). "Professor Neil Gow FMedSci FRS". London: Royal Society. Archived from the original on 29 April 2016. One or more of the preceding sentences incorporates text from the royalsociety.org website where:
    "All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License." -- "Royal Society Terms, conditions and policies". Archived from the original on 25 September 2015. Retrieved 9 March 2016.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  13. "Royal Society of Edinburgh Fellows as of 2016-05-13" (PDF). Edinburgh: Royal Society of Edinburgh. Archived from the original (PDF) on 30 March 2016.